SCHEDULE: GeoVax Labs Stakeholder Filing

Intracoastal Capital LLC and associated individuals report beneficial ownership of 9.99% of GeoVax Labs' common stock as of March 31, 2026.

Summary

• The filing is a Schedule 13G amendment reporting beneficial ownership of GeoVax Labs, Inc. common stock.
• Reporting Persons include Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC.
• As of March 31, 2026, the Reporting Persons collectively beneficially owned 233,337 shares of common stock.
• This ownership represents approximately 9.99% of the outstanding common stock.
• The reported ownership includes 121,200 shares held directly by Intracoastal Capital LLC and 112,137 shares issuable upon exercise of a warrant (Intracoastal Warrant 1).
• Several other warrants (Warrants 1 through 5) held by Intracoastal Capital LLC have blocker provisions that limit the exercise of shares, preventing beneficial ownership from exceeding certain thresholds (9.99% or 4.99%).
• Without these blocker provisions and assuming certain warrants were exercisable, the Reporting Persons could have beneficially owned up to 1,226,217 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting existing ownership and warrant positions with strategic limitations, rather than indicating new developments or significant shifts in strategy.

Positives

• The Reporting Persons hold a significant stake, nearly reaching the 10% threshold, indicating substantial investor interest.
• The existence of multiple warrants suggests potential for future share acquisition, which could increase the company's capital if exercised.

Negatives

• The presence of 'blocker provisions' in multiple warrants indicates a deliberate strategy to limit ownership and avoid triggering higher disclosure requirements or potential regulatory scrutiny associated with exceeding certain ownership percentages.
• The inability to exercise a significant number of shares due to these blockers suggests potential limitations on the Reporting Persons' ability to influence the company's control or benefit from a larger stake.

Risks

• The blocker provisions in the warrants limit the Reporting Persons' ability to acquire more shares, potentially capping their influence and upside.
• The need for stockholder approval for exercising certain warrants (Warrants 4 and 5) introduces uncertainty regarding future share acquisition.

Future Outlook

The future outlook is indirectly influenced by the potential exercise of warrants. However, the presence of blocker provisions and the requirement for stockholder approval for some warrants introduce significant uncertainty regarding the actual number of shares that may be acquired in the future.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard for institutional investors and significant shareholders to report their holdings. The use of blocker provisions is a common strategy to manage ownership levels and comply with regulatory thresholds, particularly in companies with a high number of outstanding warrants or convertible securities.

Stakeholder Impact

• Shareholders: The filing confirms a significant ownership stake by Intracoastal Capital LLC and associated individuals, which could influence market perception. The blocker provisions suggest a controlled approach to increasing this stake.
• Management: The reporting persons' ownership level may warrant engagement with the company's management or board, depending on their investment strategy.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The Reporting Persons may exercise their warrants, subject to the terms and blocker provisions outlined in the filing.
• Stockholder approval may be required for the exercise of Intracoastal Warrants 4 and 5.

Key Dates

Keywords

Schedule 13G, GeoVax Labs, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Beneficial Ownership, Common Stock, Warrants, Blocker Provisions, SEC Filing